Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide is an experimental small molecule belonging to the benzenesulfonamides class. It is a piperazinecarboxylic acid derivative with a sulfonamide group and has been described as a metalloprotease inhibitor. Patent literature suggests its potential use in treating diseases characterized by metalloprotease activity, such as musculoskeletal diseases and cachexia. There are no approved indications or clinical trials reported for this compound[1][5].
- Other names
- N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide(3R)-3-(Hydroxycarbamoyl)-4-[(4-méthoxyphényl)sulfonyl]-1-pipérazinecarboxylate de benzyle1-Piperazinecarboxylic acid, 3-[(hydroxyamino)carbonyl]-4-[(4-methoxyphenyl)sulfonyl]-, phenylmethyl ester, (3R)Benzyl (3R)-3-(hydroxycarbamoyl)-4-[ (4-methoxyphenyl)sulfonyl ]piperazine -1-carbox ylate
02
Targets
MMP12 (Macrophage Metalloelastase)
Beyond the preview
Go deeper on N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide.